Results 141 to 150 of about 245,985 (307)

Jonathan D. Katz at the Queer History of Fashion Symposium

open access: yes
Jonathan D. Katz, director of the doctoral program in visual studies at the SUNY Buffalo, presents "Queer Self-Fashioning" at The Museum at FIT's 13th fashion symposium, A Queer History of Fashion, held November 8-9, 2013.

core  

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Rapunzel Syndrome complicated by dual jejuno-jejunal intussusceptions: a case report. [PDF]

open access: yesInt J Surg Case Rep
Abed V   +5 more
europepmc   +1 more source

Exhibiting Fashion Symposium: José Teunissen “Different Ways of Exhibiting Fashion in the Museum”

open access: yes
The Museum at FIT presented Exhibiting Fashion, its twenty-first academic symposium on Friday, March 8, 2019. This symposium explored the history of fashion curating, the different ways fashion is displayed in museum settings, and how national and ...

core  

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Prof. Barry Ginsburg’s Reflections of Diversity at FIT: Oral History – Diversity Council

open access: yes
FIT Diversity Oral History Project: Barry Ginsburg, Professor Emeritus, Science & Mathematics Department, School of Liberal Arts.Presented by: Diversity Council at FIT: Oral History Committee.Recorded: December 2, 2009.Presented: April 29, 2010 as part ...

core  

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy